|
Match
|
Document |
Document Title |
|
|
7338948 |
Use of quetiapine
A method of treating Attention Deficit Hyperactivity Disorder, Conduct Disorder and related disorders which comprises using the atypical antipychotic agent quetiapine.
|
|
|
7304047 |
Method of treating substance abuse with quetiapine
This invention relates to a method of treating Substance Use such as Substance Abuse or Substance Dependence and in particular to the use of quetiapine in treating such disorders.
|
|
|
7238686 |
Polymorphs of quetiapine fumarate
The present invention relates to novel polymorphic forms of quetiapine fumarate, processes for their preparation and pharmaceutical compositions containing them.
|
|
|
7022700 |
Method of increasing neutrophil production using optically-pure (R)-2,3-benzodiazepines
Compounds according to formula I:
wherein R 1 , R 2 , R 3 , R 4 , R 5 and n are as defined herein, are administered to increase neutrophil levels in mammels.
|
|
|
7022692 |
Quetiapine granules
Granule formulation of quetiapine and pharmaceutically acceptable salt thereof are described, as are their preparation and their use in treating diseases of the central nervous system such as...
|
|
|
6936601 |
Compositions for treating pain
The present invention provides compositions for treating pain using an atypical antipsychotic compound that is seroquel in combination with another Drug Used in the Treatment of Pain.
|
|
|
6890919 |
Atypical antipsychotic agents having low affinity for the D2 receptor
The present invention provides novel compounds of Formula I:
The invention further relates to pharmaceutical compositions comprising compounds of Formula I and to methods of using compounds of...
|
|
|
6683072 |
Compositions and methods for treatment of irritable bowel syndrome and nonulcer dyspepsia
Compounds according to the formula as defined herein are administered for the treatment of irritable bowel syndrome and nonulcer dyspepsia.
|
|
|
6630462 |
Delta agonist analgesics
Methods and pharmaceutical compositions for the treatment of pain, preferably with lowered risk of induction of seizure in a patient. The compositions contain active compounds that are tricyclic δ...
|
|
|
6599896 |
Use of tianeptine in the production of medicaments to treat neurodegenerative pathologies
The invention relates to the use of tianeptine or enantiomers thereof in obtaining medicaments for use in the treatment of neurodegenerative pathologies.
|
|
|
6566389 |
Therapeutic uses of melatonin
A method for treating or preventing symptoms of tardive dyskensia comprises administering melatonin to patient exhibiting or liable to develop such symptoms. The melatonin is administered in an...
|
|
|
6545057 |
Tricyclic antidepressants and their analogues as long-acting local anesthetics and analgesics
Methods and compositions of tricyclic antidepressants for inducing local long-lasting anesthesia and analgesia are provided. The methods and compositions are useful for alleviating acute and...
|
|
|
6372734 |
Crystalline dibenzothiazepine derivative and its use as an antipsychotic agent
Crystalline 11-(4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl)-dibenzo[b,f]
[1,4]thiazepine (I) may be prepared by crystallizing...
|
|
|
6211171 |
Use of antidepressants for local analgesia
When administered locally, tricyclic, second generation and third generation antidepressants, such as amitriptyline and desipramine, have been shown to produce analgesia in a subject having a site...
|
|
|
6054458 |
Heterocyclic compounds
The present invention relates to novel N-substituted azaheterocyclic compounds of the general formula ##STR1## wherein X, Y, Z, R 1 , R 2 and m are as defined in the detailed part of the present...
|
|
|
5948437 |
Pharmaceutical compositions using thiazepine
The invention relates to sustained release formulations comprising 11- 4- 2-(2-hydroxyethoxy)ethyl!-1-piperazinyl!dibenzo b,f! 1,4!thiazepine or a pharmaceutically acceptable salt thereof, to...
|
|
|
5703072 |
Bicyclic nonane and decane compounds having dopamine receptor affinity
Described herein are D4 receptor-selective compounds of the general formula: ##STR1## wherein: A and B are independently selected, substituted or unsubstituted, unsaturated 5- or 6-membered, homo-...
|
|
|
5663167 |
Antipsychotic composition and method of treatment
A method for treating a serious psychotic mental illness includes the step of administering to a patient in need of such treatment a combination of (i) an α 2 -adrenergic receptor antagonist and...
|
|
|
5344828 |
Piperazinealkanoic acid and a pharmaceutical composition comprising the same
Novel polycyclic compounds represented by the following formula: A--(CH 2 ) n --COOR 1 , wherein R 1 represents a hydrogen atom or a lower alkyl group; n represents an integer of from 0 to 5; and...
|
|
|
4879288 |
Novel dibenzothiazepine antipsychotic
11-[4-[2-(2-Hydroxyethoxy)ethyl]-1-piperazinyl]dibenzo[b,f][
1,4 ]thiazepine is disclosed as a neuroleptic with a much reduced incidence of side effects such as acute dystonia and dyskinesia and...
|
|
|
4766114 |
Tricyclic compound called 5-((3-chloro-6-methyl-5,5-dioxo-6,11-dihydro-dibenzo (c,f) (1,2)thiazepin-11-yl)-amino) pentanoic acid
The invention concerns 5-[(3-chloro-6-methyl-5,5-dioxo-6,11-dihydro-dibenzo (c,f) (1,2) thiazepin-11-yl)-amino] pentanoic acid. Medicament.
|
|
|
4732895 |
α-[5-methyl-2-(pyridinyl)-1H-imidazol-4-yl]substituted-1-p iperazineethanols useful for treating hypertension
This disclosure describes novel substituted α-[5-methyl-2-pyridyl-1H-imidazol-4-yl]-1-piperazineethanol
s which possess hypotensive activity.
|
|
|
4049809 |
Solution of a oxazepine for oral or parenteral administration
Stable, soluble solutions of 2-chloro-11-(4-methyl-1-piperazinyl)-dibenz[b,f][1,4]oxazepi
ne are described, some of which are suitable for oral and others for parenteral administration.
|
|
|
4016273 |
Sustained release forms of certain oxazepines for parenteral administration
A sustained release depot form of the free base or pamoate salt of 2-chloro-11-(1-piperazinyl)-dibenz[b,f][1,4]-oxazepine or 2-chloro-11-(4-methyl-1-piperazinyl)-dibenz[b,f]-[1,4]oxazep
ine in an...
|
|
|
3966949 |
Pharmaceutical compositions and preparing same
Water-insoluble therapeutic agents having a tertiary nitrogen capable of being protonated are stabilized and solubilized via the formation of water-soluble lipophilic liquid fatty acid salts.
|
|
|
3908010 |
Basically substituted heterocycles as anti-emetics
Certain 11-basically substituted dibenzo?b,f!-?1,4!thiazepines and dibenzo?b,e! ?1,4!diazepines are useful as anti-emetics.
|
|
|
3852446 |
ORGANIC COMPOUNDS IN TREATMENT OF PSYCHOTIC DISTURBANCES
This invention concerns the use of the compound 2-nitro-11-(4-methyl-1-piperazinyl)dibenzo[b,f][1,4]-thiazep
ine, as a neuroleptic agent.
|
|
|
3726977 |
2-NITRO-11-(1-PIPERAZINYL)-DIBENZ (b,f) (1,4) OXAZEPINES COMPOSITIONS IN THE TREATMENT OF DEPRESSION
Pharmaceutical compositions containing 2-nitro-11-(1-piperazinyl)-dibenz [b,f] [1,4] oxazepine or its pharmaceutically acceptable acid addition salts are useful in the treatment of depression.
|
|
|
3683084 |
BASICALLY SUBSTITUTED HETEROCYCLES AS ANTI-EMETICS
Certain 11-basically substituted dibenz[b,f][1,4]oxazepines are useful as anti-emetics. 3 Claims, No Drawings
|
|
|
3412193 |
11-(4-methyl-1-piperazinyl)dibenz[b, f][1, 4]oxazepines or thiazepines for controlling fertility
|
|
|
3786145 |
Title is not available
|
|
|
3705245 |
Title is not available
|
|
|
3663696 |
Title is not available
|
|
|
3560622 |
Title is not available
|